BRCA1 and ovarian cancer: The level of BRCA1/2 expression was reported to be downregulated by the PI3K inhibitor, BKM120, in wild-type PIK3CA ovarian cancer cells (OVCA433, OVCAR-5, and OVCAR-8), without the involvement of ERK activation (Wang et al., 2016).